Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis


PÜRNAK T. , Efe C., KAV T. , Wahlin S., Ozaslan E.

DIGESTIVE DISEASES AND SCIENCES, cilt.62, sa.10, ss.2900-2907, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 62 Konu: 10
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1007/s10620-017-4728-2
  • Dergi Adı: DIGESTIVE DISEASES AND SCIENCES
  • Sayfa Sayıları: ss.2900-2907

Özet

Beyond available guidelines, therapy of autoimmune hepatitis (AIH) shows wide variation among physicians. We compared two regimens for treatment naive AIH: one recommended protocol with an initial prednisolone dose of 30 mg/day and our own 40 mg/day prednisolone with a slow dose tapering protocol. We analyzed the safety, response rates, and outcomes for two groups of treated patients.